Japanese drug maker Takeda has entered into collaboration with Massachusetts biotech Moderna to bring 50 million doses of its mRNA-based COVID-19 shots to Japanese shores. Takeda will import and distribute mRNA-1273 starting in the first half of 2021, besides handling local regulatory approvals. Moderna’s vaccine is currently undergoing a 30,000-patient …
Read More »